Pathology of the Nervous System in Von Hippel-Lindau Disease
Open Access
- 9 May 2015
- journal article
- Published by Codon Publications in Journal of Kidney Cancer
- Vol. 2 (3) , 114-129
Abstract
Von Hippel-Lindau (VHL) disease is a tumor syndrome that frequently involves the central nervous system (CNS). It is caused by germline mutation of the VHL gene. Subsequent VHL inactivation in selected cells is followed by numerous well-characterized molecular consequences, in particular, activation and stabilization of hypoxia-inducible factors HIF1 and HIF2. The link between VHL gene inactivation and tumorigenesis remains poorly understood. Hemangioblastomas are the most common manifestation in the CNS; however, CNS invasion by VHL disease-associated endolymphatic sac tumors or metastatic renal cancer also occur, and their differentiation from primary hemangioblastoma may be challenging. Finally, in this review, we present recent morphologic insights on the developmental concept of VHL tumorigenesis which is best explained by pathologic persistence of temporary embryonic progenitor cells.Keywords
This publication has 95 references indexed in Scilit:
- Developmentally arrested structures preceding cerebellar tumors in von Hippel–Lindau diseaseLaboratory Investigation, 2011
- On the Stem Cell Origin of CancerThe American Journal of Pathology, 2010
- The role of oxygen availability in embryonic development and stem cell functionNature Reviews Molecular Cell Biology, 2008
- Origin of Endolymphatic Sac TumorHead and Neck Pathology, 2007
- Hypoxia-inducible factor–2 (HIF-2) regulates hepatic erythropoietin in vivoJournal of Clinical Investigation, 2007
- von Hippel-Lindau Disease-Associated Hemangioblastomas Are Derived from Embryologic Multipotent CellsPLOS Medicine, 2007
- Acute postnatal ablation of Hif-2 α results in anemiaProceedings of the National Academy of Sciences, 2007
- Multiple Tumor Types May Originate from Bone Marrow-Derived CellsNeoplasia, 2006
- Second hit deletion size in von Hippel–Lindau diseaseAnnals of Neurology, 2005
- Hereditary cancer: Two hits revisitedJournal of Cancer Research and Clinical Oncology, 1996